Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study.

BACKGROUND The incidence of cardiac device infection is not well understood. Bloodstream infection (BSI) in patients with permanent pacemakers or implantable cardioverter-defibrillators (hereafter, defibrillators) may reflect device infection. METHODS Retrospective, population-based cohort study of all adult patients with cardiac devices who resided in Olmsted County, Minnesota, from 1975 to 2004. The medical linkage-system of the Rochester Epidemiology Project and standardized criteria were used to identify all cases of BSI and device infection. The incidence of device infection was calculated with person-years of follow-up after device implantation. RESULTS A total of 1524 patients with cardiac devices were included in the cohort. Total person-time of follow-up was 7578 years. The incidence of definite device infection was 1.9 per 1000 device-years (95% confidence interval [CI], 1.1-3.1). The incidence of pocket infection without BSI was 1.37 per 1000 device-years (95% CI, 0.62-3.05), and pocket infection with BSI or device-related endocarditis 1.14 per 1000 device years (95% CI, 0.47-2.74). The cumulative probability of device infection was higher among patients with defibrillators compared with those with pacemakers, P<.001. Twelve (54.6%) of 22 cases of Staphylococcus aureus BSI had definite or possible cardiac device infection vs 3 (12.0%) of 25 cases of bloodstream infection due to gram-negative bacilli (P = .004). CONCLUSIONS To our knowledge, this is the first population-based study to describe the incidence of cardiac device infection. Device infection was common during episodes of S aureus BSI. The rate of cardiac device infection was higher in patients with defibrillators than in those with pacemakers.

[1]  D. Wennberg,et al.  The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. , 2005, Journal of the American College of Cardiology.

[2]  P. Heidenreich,et al.  Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. , 2004, American heart journal.

[3]  B. Gersh,et al.  Permanent pacemaker infections: characterization and management. , 1981, The American journal of cardiology.

[4]  David L Hayes,et al.  Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  D Lacroix,et al.  Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. , 1997, Circulation.

[6]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[7]  Vance G. Fowler,et al.  Staphylococcus aureus Bacteremia in Patients With Permanent Pacemakers or Implantable Cardioverter-Defibrillators , 2001, Circulation.

[8]  T. Nealon,et al.  Four hundred consecutive patients with permanent transvenous pacemakers. , 1975, The Journal of thoracic and cardiovascular surgery.

[9]  G. Bluhm.  Pacemaker infections. A clinical study with special reference to prophylactic use of some isoxazolyl penicillins. , 2009, Acta medica Scandinavica. Supplementum.

[10]  J. Molina.  Undertreatment and overtreatment of patients with infected antiarrhythmic implantable devices. , 1997, The Annals of thoracic surgery.

[11]  I. Lossos,et al.  Pacemaker endocarditis. Report of 44 cases and review of the literature. , 1994, Medicine.

[12]  A. Krahn,et al.  Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. , 2006, JAMA.

[13]  K. Kupka,et al.  International classification of diseases: ninth revision. , 1978, WHO chronicle.

[14]  David Longworth,et al.  Diagnosis and Management of Infections Involving Implantable Electrophysiologic Cardiac Devices , 2000, Annals of Internal Medicine.

[15]  V. Fowler,et al.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  F. Raffi,et al.  Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  D. Maraganore,et al.  Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990 , 1999, Neurology.

[18]  R. Darouiche.  Device-associated infections: a macroproblem that starts with microadherence. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  M. Aronson,et al.  Diagnostic Decision: Blood Cultures , 1987 .

[20]  Walter R Wilson,et al.  Nonvalvular Cardiovascular Device–Related Infections , 2003, Circulation.

[21]  D. Durack,et al.  New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. , 1994, The American journal of medicine.

[22]  L. Melton,et al.  History of the Rochester Epidemiology Project. , 1996, Mayo Clinic proceedings.

[23]  V. N. Slee,et al.  The International Classification of Diseases: ninth revision (ICD-9) , 1978, Annals of internal medicine.

[24]  R. Haug.  New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings , 1994 .

[25]  Daniel J Sexton,et al.  Health CareAssociated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections , 2002, Annals of Internal Medicine.

[26]  J. Matloff,et al.  Avulsion of a tricuspid valve leaflet during traction on an infected, entrapped endocardial pacemaker electrode. The role of electrode design. , 1977, The Journal of thoracic and cardiovascular surgery.

[27]  R. Holmes,et al.  Adherence of bacteria to heart valves in vitro. , 1975, The Journal of clinical investigation.

[28]  L Goldman,et al.  Contaminant blood cultures and resource utilization. The true consequences of false-positive results. , 1991, JAMA.

[29]  M. Weinstein,et al.  The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. , 1983, Reviews of infectious diseases.

[30]  Paul N Valenstein,et al.  Trends in blood culture contamination: a College of American Pathologists Q-Tracks study of 356 institutions. , 2005, Archives of pathology & laboratory medicine.

[31]  R. Fairbrother.  Blood cultures. , 1949, The Practitioner.

[32]  A. Pavie,et al.  Pacemaker infective endocarditis. , 1998, The American journal of cardiology.

[33]  Xavier Duval,et al.  Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  R. Courcol,et al.  Involvement of Adherence and Adhesion Staphylococcus epidermidis Genes in Pacemaker Lead-Associated Infections , 2003, Journal of Clinical Microbiology.

[35]  R. Macgregor,et al.  Evaluation of positive blood cultures. Guidelines for early differentiation of contaminated from valid positive cultures. , 1972, Archives of internal medicine.